Data as of Sep 22
| -0.07 / -0.62%|
The 4 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 20.50, with a high estimate of 25.00 and a low estimate of 16.00. The median estimate represents a +84.02% increase from the last price of 11.14.
The current consensus among 4 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.